ImmuPharma plc, a specialist drug discovery and development company, has selected Thermo Fisher Scientific as the contract ...

BostonGene announced a strategic partnership with Kyoto University, supporting a multicenter Phase II trial led by Kyoto’s Dr ...

Bayer and Kairos Pharma will study Kairos’ lead antibody, ENV-105 (carotuximab), in combination with Bayer’s Xofigo ...

PolyPid and Azurity Pharmaceuticals are partnering to commercialize D-PLEX 100, preventing surgical site infections (SSIs), ...

Forge Biologics, part of Ajinomoto Bio-Pharma Services, is partnering with Restore Vision on a gene therapy for retinitis ...

Wheeler Bio, a biologics-focused CDMO, is appointing Rajesh Beri, PhD, as its new Chief Development Officer. Beri’s expertise ...

ACG has appointed Lalit Kasliwal as Group Chief Financial Officer (CFO), where he will lead ACG’s global finance function, ...

Xmoor Pharma and Evox Therapeutics have completed a technology transfer program for Evox's exosome-enabled gene editing ...

Samsung Biologics has launched an all-cash public tender offer to acquire 100% of the fully diluted share capital of ...

AdvanCell, a clinical-stage radiopharmaceutical company developing targeted alpha therapies for cancer, has closed an ...

Natoli Engineering Company Inc. has acquired Scheu & Kniss, a company with 100+ of experience providing tablet press ...

As artificial intelligence becomes more embedded in clinical development, the focus is shifting from capability to trust. At ...